Blood Test Could Spare Men With Advanced Prostate Cancer From Futile Chemotherapy
December 22, 2025
December 22, 2025
LONDON, England, Dec. 22 -- The Institute of Cancer Research issued the following news:
* * *
Blood test could spare men with advanced prostate cancer from futile chemotherapy
New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer. Using samples from more than 200 men, researchers found a significant association between chromosomal instability in circulating tumour cells (CTCs) - those shed f . . .
* * *
Blood test could spare men with advanced prostate cancer from futile chemotherapy
New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer. Using samples from more than 200 men, researchers found a significant association between chromosomal instability in circulating tumour cells (CTCs) - those shed f . . .